In this publication, we explore what makes a successful pharma launch from developing insight that drives behaviour change to lean launches and multi-indication launches, as well as an evaluation of the CAR-T market.
We’re posting all new articles on our parent website fishawack.com
Our parent company Fishawack Health has launched a new magazine with a first issue unpacking rare disease.
Precision and personalised medicines are more than products, they are services in their own right. So, how should pharma approach this uncharted territory to ensure targeted therapies work for patients?